Trials / Conditions / EGFR Mutation Positive Non-small Cell Lung Cancer
EGFR Mutation Positive Non-small Cell Lung Cancer
4 registered clinical trials studyying EGFR Mutation Positive Non-small Cell Lung Cancer — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer NCT07315113 | Nuvectis Pharma, Inc. | Phase 1 |
| Unknown | First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Sma NCT02906163 | SciClone Pharmaceuticals | Phase 1 / Phase 2 |
| Unknown | Genetics of EGFR (Epidermal Growth Factor Receptor) Mutation Study NCT01838577 | European Organisation for Research and Treatment of Cancer - EORTC | — |
| Unknown | Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis NCT01776684 | Samsung Medical Center | N/A |